Anesthesiologist Assistants

The current standard of care in the anesthesia care team model allows one supervising anesthesiologist to medically direct up to four concurrent CRNA or AA cases—the 1:4 ratio embedded in Medicare medical direction billing rules (7 conditions of payment, CFR 415.110). AI-enhanced monitoring platforms (Edwards HPI, Masimo Root, GE AoA) are actively marketed to anesthesiology departments with the explicit claim of reducing cognitive load and enabling 'enhanced supervision.' Health system administrators and anesthesiology practice groups are beginning to pilot 1:5 and 1:6 ratio models in low-acuity ambulatory settings under 'general supervision' billing, which has no CMS-mandated ratio ceiling. The AANA and ASA are engaged in ongoing scope-of-practice and billing rule battles that will determine whether ratio expansion becomes normalized.

Multiple closed-loop propofol sedation and anesthesia systems have achieved CE marking in Europe and published non-inferiority RCT data: the iControl-RP system (University of British Columbia), McSleepy (McGill University), CLADS (University of Liège), and commercial systems from Fresenius Kabi and B. Braun. The FDA's De Novo and 510(k) pathways for Software as a Medical Device (SaMD) have been clarified by the 2023 Digital Health Center of Excellence guidance. A likely FDA strategy is approval for procedural sedation (colonoscopy, bronchoscopy) first—lower acuity, better-defined endpoints, existing precedent from Sedasys—before general anesthesia indications. ICU sedation protocols represent a parallel pathway. Johnson & Johnson MedTech, following its acquisition of assets from Ethicon's robotics portfolio, and Fresenius Kabi have both disclosed regulatory interactions regarding closed-loop sedation in FDA 510(k) databases.